The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis-Reference-Cited by-同舟云学术

The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis

Published:2014-06 Issue: Volume:81 Page:142-152
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Carmo Marta R.S.,Menezes Ana Paula F.,Nunes Ana Carla L.,Pliássova Anna^ORCID,Rolo Anabela P.,Palmeira Carlos M.,Cunha Rodrigo A.^ORCID,Canas Paula M.,Andrade Geanne M.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference88 articles.

1. Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat;Able;Br. J. Pharmacol.,2011

2. Parkinson's disease: pathophysiology;Agid;Lancet,1991

3. Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals;Alloisio;FEBS Lett.,2008

4. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: an immunohistological study;Amadio;Purinergic Signal,2007

5. ATP induces the death of developing avian retinal neurons in culture via activation of P2X7 and glutamate receptors;Anccasi;Purinergic Signal,2013

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The P2X7 receptor mediates NADPH transport across the plasma membrane;Biochemical and Biophysical Research Communications;2024-12

2. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7;Cell Calcium;2024-11

3. Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08

4. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders;Frontiers in Pharmacology;2024-07-30

5. Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-30